Skip to main content

Table 2 Virus titers (TCID 50 */50 μl) 48 h post infection without or in presence of anti-CAR (RmcB), anti-DAF (BRIC 216), or both

From: Study of Coxsackie B viruses interactions with Coxsackie Adenovirus receptor and Decay-Accelerating Factor using Human CaCo-2 cell line

Isolate

Control (No Ab)

+BRIC216

+ RcmB

RcmB + BRIC216

Nancy

107.5

103

103

102.5

Rec (B3/B4)

108

104

103.7

102

B3-37335

107.3

107

103

102

B3-523-21

107.3

103.6

103.5

102

B3-02

106.6

103.9

103.3

102

B4N

107

107

104

102

B4-37428

106.6

106

103.3

103

B4 JVB

107.3

107

104

102.7

B4-0612

105.3

105

103.7

102

B4-07

105.3

105

103.5

102

B5-37534

107

103

103

102

B5-2003

108

104.9

103

102

B5-99

106.33

106

103

102

B5-2000

107.3

107

104

102

B6-041

105.9

105

103.5

102

B2-37222

106.3

106

104

102.5

B2N

106

106

103.5

102.5

B2-0610 M

105.3

105

103

102

B2-2000

106.3

106

104

102.7

B1-032

107.6

103.9

103

103

B1-0609

106.3

106

103

102

B1-0807

107.6

104

103

102

  1. (*) TCID50: 50% Tissue Culture Infective Dose.
  2. Ab: antibodies.